CCL18, derived from alveolar macrophages (a cell type exposed directly to smoke) is a known mediator of fibrogenesis implicated in the smoking-related lung disease IPF, and in the ILD associated with systemic sclerosis, another disease where fibrocytes play a role [23]. Here, CCL18 is linked to systemic sclerosis.